Cryptogenic cholestasis in young and adults: ATP8B1, ABCB11, ABCB4, and TJP2 gene variants analysis by high-throughput sequencing

Overview of attention for article published in Journal of Gastroenterology, December 2017

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

twitter: 1 X user

patent: 33 patents

Readers on

mendeley: 33 Mendeley

Summary X Patents

So far, Altmetric has seen 33 patents that reference this research output.

Benzothia(di)azepine compounds and their use as bile acid modulators

Grant US-11891368-B2

United States of America

06 Feb 2024

Solid formulation and method for preventing or reducing coloration thereof

Grant US-11844822-B2

United States of America

19 Dec 2023

Pharmaceutical formulation of odevixibat

Grant US-11802115-B2

United States of America

31 Oct 2023

Pharmaceutical formulation of odevixibat

Grant US-11801226-B2

United States of America

31 Oct 2023

Benzothiazepine compounds and their use as bile acid modulators

Grant US-11773071-B2

United States of America

03 Oct 2023

IBAT inhibitors for the treatment of liver diseases

Grant US-11732006-B2

United States of America

22 Aug 2023

Benzothia(di)azepine compounds and their use as bile acid modulators

Grant US-11708340-B2

United States of America

25 Jul 2023

Benzothiadiazepine compounds and their use as bile acid modulators

Grant US-11603359-B2

United States of America

14 Mar 2023

Treating progressive familial intrahepatic cholestasis (PFIC) with IBAT inhibitors

Grant US-11583539-B2

United States of America

21 Feb 2023

Benzothia(di)azepine compounds and their use as bile acid modulators

Grant US-11572350-B1

United States of America

07 Feb 2023

In vitro method for determining the adsorbing capacity of an insoluble adsorbant

Grant US-11549878-B2

United States of America

10 Jan 2023

Benzothia(di)azepine compounds and their use as bile acid modulators

Grant US-11377429-B2

United States of America

05 Jul 2022

Crystal modifications of odevixibat

Grant US-11365182-B2

United States of America

21 Jun 2022

Benzothia(di)azepine compounds and their use as bile acid modulators

Grant US-11306064-B2

United States of America

19 Apr 2022

Benzothia(di)azepine compounds and their use as bile acid modulators

Grant US-11267794-B2

United States of America

08 Mar 2022

IBAT inhibitors for the treatment of liver diseases

Grant US-11261212-B2

United States of America

01 Mar 2022

Benzothiadiazepine compounds and their use as bile acid modulators

Grant US-11225466-B2

United States of America

18 Jan 2022

Benzothia(di)azepine compounds and their use as bile acid modulators

Grant US-11180465-B2

United States of America

23 Nov 2021

Benzothia(di)azepine compounds and their use as bile acid modulators

Grant US-11111224-B2

United States of America

07 Sep 2021

Benzothiazepine compounds and their use as bile acid modulators

Grant US-11014898-B1

United States of America

25 May 2021

Oral cholestyramine formulation and use thereof

Grant US-11007142-B2

United States of America

18 May 2021

IBAT inhibitors for the treatment of liver diseases

Grant US-10981952-B2

United States of America

20 Apr 2021

Benzothiazepine compounds and their use as bile acid modulators

Grant US-10975045-B2

United States of America

13 Apr 2021

Crystal modifications of odevixibat

Grant US-10975046-B2

United States of America

13 Apr 2021

Benzothiadiazepine compounds and their use as bile acid modulators

Grant US-10941127-B2

United States of America

09 Mar 2021

Oral cholestyramine formulation and use thereof

Grant US-10864228-B2

United States of America

15 Dec 2020

Oral cholestyramine formulation and use thereof

Grant US-10799527-B2

United States of America

13 Oct 2020

Benzothia(di)azepine compounds and their use as bile acid modulators

Grant US-10793534-B2

United States of America

06 Oct 2020

Oral cholestyramine formulation and use thereof

Grant US-10786529-B2

United States of America

29 Sep 2020

Oral cholestyramine formulation and use thereof

Grant US-10758563-B2

United States of America

01 Sep 2020

Oral cholestyramine formulation and use thereof

Grant US-10722457-B2

United States of America

28 Jul 2020

Solid formulation and method for preventing or reducing coloration thereof

Grant US-10709755-B2

United States of America

14 Jul 2020

Cholestyramine pellets and methods for preparation thereof

Grant US-10610543-B2

United States of America

07 Apr 2020